Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore Wein

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|September 4, 2020
New View on the Canadian Burden of Stroke: Productivity Loss in Adults Who Return to WorkTheodore Wein, Johanna Mancini, Raina M Rogoza, et al.
Headache|November 15, 2012
An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptanStephen H Landy, Stewart J Tepper, Theodore Wein, et al.
Medicine|July 27, 2023
Treatment of adult spasticity with Botox (onabotulinumtoxinA): Development, insights, and impactAlberto Esquenazi, Wolfgang H Jost, Catherine C Turkel, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|September 28, 2016
Poster 312 Muscle Selection Patterns for Injection of OnabotulinumtoxinA in Adult Patients with Post-Stroke Lower-Limb Spasticity Influence Outcome: Results from a Double-Blind, Placebo-Controlled Phase 3 Clinical TrialAlberto Esquenazi, Carolyn Geis, Theodore Wein, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|January 14, 2018
OnabotulinumtoxinA for the Treatment of Poststroke Distal Lower Limb Spasticity: A Randomized TrialTheodore Wein, Alberto Esquenazi, Wolfgang H Jost, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|January 29, 2019
Adherence to Guidelines at a Stroke Prevention Clinic: A Follow-up StudyBing Yu Chen, Heather Perkins, Eric Ehrensperger, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 2, 2019
Long-term Safety and Dosing of OnabotulinumtoxinA: A Prospective, Observational StudyTheodore Wein, Mandar Jog, Meetu Bhogal, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 20, 2016
Real-World, Long-Term Quality of Life Following Therapeutic OnabotulinumtoxinA TreatmentMandar Jog, Theodore Wein, Meetu Bhogal, et al.
JMIR Public Health and Surveillance|December 7, 2020
Perspective of an International Online Patient and Caregiver Community on the Burden of Spasticity and Impact of Botulinum Neurotoxin Therapy: Survey StudyAtul T Patel, Theodore Wein, Laxman B Bahroo, et al.
Toxins|April 3, 2021
BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel ApproachAlessio Baricich, Theodore Wein, Nicoletta Cinone, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|September 4, 2020
New View on the Canadian Burden of Stroke: Productivity Loss in Adults Who Return to WorkTheodore Wein, Johanna Mancini, Raina M Rogoza, et al.
Headache|November 15, 2012
An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptanStephen H Landy, Stewart J Tepper, Theodore Wein, et al.
Medicine|July 27, 2023
Treatment of adult spasticity with Botox (onabotulinumtoxinA): Development, insights, and impactAlberto Esquenazi, Wolfgang H Jost, Catherine C Turkel, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|September 28, 2016
Poster 312 Muscle Selection Patterns for Injection of OnabotulinumtoxinA in Adult Patients with Post-Stroke Lower-Limb Spasticity Influence Outcome: Results from a Double-Blind, Placebo-Controlled Phase 3 Clinical TrialAlberto Esquenazi, Carolyn Geis, Theodore Wein, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|January 14, 2018
OnabotulinumtoxinA for the Treatment of Poststroke Distal Lower Limb Spasticity: A Randomized TrialTheodore Wein, Alberto Esquenazi, Wolfgang H Jost, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|January 29, 2019
Adherence to Guidelines at a Stroke Prevention Clinic: A Follow-up StudyBing Yu Chen, Heather Perkins, Eric Ehrensperger, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 2, 2019
Long-term Safety and Dosing of OnabotulinumtoxinA: A Prospective, Observational StudyTheodore Wein, Mandar Jog, Meetu Bhogal, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 20, 2016
Real-World, Long-Term Quality of Life Following Therapeutic OnabotulinumtoxinA TreatmentMandar Jog, Theodore Wein, Meetu Bhogal, et al.
JMIR Public Health and Surveillance|December 7, 2020
Perspective of an International Online Patient and Caregiver Community on the Burden of Spasticity and Impact of Botulinum Neurotoxin Therapy: Survey StudyAtul T Patel, Theodore Wein, Laxman B Bahroo, et al.
Toxins|April 3, 2021
BoNT-A for Post-Stroke Spasticity: Guidance on Unmet Clinical Needs from a Delphi Panel ApproachAlessio Baricich, Theodore Wein, Nicoletta Cinone, et al.
Pageof 4